BGBIO — Bergenbio ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK68.95m
- -NOK70.39m
- NOK0.85m
- 12
- 20
- 53
- 15
Annual cashflow statement for Bergenbio ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -257 | -309 | -302 | -190 | -139 |
| Depreciation | |||||
| Non-Cash Items | 8.44 | -0.389 | 2.83 | -1.49 | -2.78 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.6 | 5.1 | 10.2 | -33.4 | -11.6 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -234 | -303 | -288 | -225 | -153 |
| Capital Expenditures | -0.067 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.62 | 3.13 | 3.25 | 3.06 | 3.69 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.55 | 3.13 | 3.25 | 3.06 | 3.69 |
| Financing Cash Flow Items | — | -0.069 | -0.007 | -37 | -8.83 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 700 | 16 | 2.9 | 225 | 130 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 468 | -285 | -286 | 5.62 | -16.3 |